Search

Fingolimod, under the trade name Gilenya, the first oral drug therapy for the treatment of MS, is now available under the direction of a neurologist. Gilenya is licensed as a second line therapy, making it suitable for people that have failed on conventional first line therapies or those individuals with highly active MS.

Thank you so much to Kingsland NS in Roscommon, who couldn’t participate in the MS READaTHON this year but still wanted to support MS Ireland. They decided to hold a Halloween Party instead with all funds raised going to MS Ireland! Some fantastic costumes guys!

CONGRATULATIONS to our two lucky winners, Rachel Douglas and Sue Carroll. They both win a signed copy of  "Sally Go Round the Stars” by Sarah Webb & Claire Ranson.

Now, if you want to be in with a chance of winning some MS READaTHON goodies, simply answer the question below and you could win some pretty great books.

A big CONGRATULATIONS to Aghabullogue National School. The answer to last week's question was 'The Dormouse'. Prizes are on the way guys!

Very BIG THANKS to all at Mean Scoil Nua an Leith-Triuigh, Kerry who organised their first ever 'Literacy Week'. Well done guys from everyone at MS READAaTHON H.Q.

Diana Cassidy of the Shiatsu Society of Ireland seen here presents a cheque for €1184 to Patricia and Carmel, MS Ireland, Cork.

We are very excited at MS READaTHON HQ... Only ONE days to go before the 'Great Prize Draw'. Tune in on Thursday, 15th December to RTE 2 Elev8! All lucky winners will be announced on the day :)

We are thrilled to announce that our friend Lisa Weston, Arbonne Independent Consultant is holding a VIP Style Evening to benefit the Friends of the Care Centre fund.

 
The NAI's National Conference "Securing Resources for Neurological Care in a Recession" will take place on Tuesday 6th March in the Radisson Hotel, Golden Lane, Dublin 8. The event will feature key updates from the consultants leading each of the four national programmes in neurological care as well as promoting Neuronetwork, the NAI's pioneering one stop link to non statutory neurological services and supports